Literature DB >> 19949002

Metformin, B(12), and enhanced breast cancer response to chemotherapy.

April Garcia, Glenn Tisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19949002     DOI： 10.1200/JCO.2009.25.7857

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Metformin and cancer: new applications for an old drug.

Authors:  Taxiarchis V Kourelis; Robert D Siegel
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

2.  Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.

Authors:  Mary R Welch; Christian Grommes
Journal:  CNS Oncol       Date:  2013-05

3.  Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).

Authors:  Jisun Kim; Woosung Lim; Eun-Kyu Kim; Min-Kyoon Kim; Nam-Sun Paik; Sang-Seol Jeong; Jung-Han Yoon; Chan Heun Park; Sei Hyun Ahn; Lee Su Kim; Sehwan Han; Seok Jin Nam; Han-Sung Kang; Seung Il Kim; Young Bum Yoo; Joon Jeong; Tae Hyun Kim; Taewoo Kang; Sung-Won Kim; Yongsik Jung; Jeong Eon Lee; Ku Sang Kim; Jong-Han Yu; Byung Joo Chae; So-Youn Jung; Eunyoung Kang; Su Yun Choi; Hyeong-Gon Moon; Dong-Young Noh; Wonshik Han
Journal:  BMC Cancer       Date:  2014-03-10       Impact factor: 4.430

4.  Metformin and cancer: An existing drug for cancer prevention and therapy.

Authors:  Fuming Zi; Huapu Zi; Yi Li; Jingsong He; Qingzhi Shi; Zhen Cai
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

Review 5.  Anti-tumor activity of metformin: from metabolic and epigenetic perspectives.

Authors:  Xilan Yu; Wuxiang Mao; Yansheng Zhai; Chong Tong; Min Liu; Lixin Ma; Xiaolan Yu; Shanshan Li
Journal:  Oncotarget       Date:  2017-01-17

6.  Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment.

Authors:  L E Anselmino; M V Baglioni; F Malizia; N Cesatti Laluce; C Borini Etichetti; V L Martínez Marignac; V Rozados; O G Scharovsky; J Girardini; M J Rico; M Menacho Márquez
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

7.  The influence of metformin in the etiology of selected cancers.

Authors:  Monika Pawałowska; Anna Markowska
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

8.  Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.

Authors:  Bruna Corominas-Faja; Rosa Quirantes-Piné; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Sílvia Cufí; Begoña Martin-Castillo; Vicente Micol; Jorge Joven; Antonio Segura-Carretero; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2012-07       Impact factor: 5.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.